Table 3.
Antibody | Immunogenicity score |
---|---|
Pembrolizumab | 35 |
Ab2001.10 | 63 |
Omalizumab | 76 |
Sintilimab | 79 |
Ab2001.08 (JMB2002) | 85 |
Trastuzumab | 92 |
Nivolumab | 105 |
Imdevimab (REGN10987) | 113 |
Dacetuzumab | 150 |
Adalimumab | 160 |
Roledumab | 173 |
CB6 | 174 |
Lorvotuzumab | 213 |